Andrew P. Han

The firm also revealed consumables reagent kit pricing for the instrument, which uses a new sequencing-by-binding method that PacBio says provides high accuracy.

The firm also hosted Niall Lennon from the Broad Institute, the first customer to receive a NovaSeq X, and offered more details on other products.

Backed by NanoString Technologies and employing the firm’s GeoMx and CosMx platforms, the Spatial Atlas of Human Anatomy project shared data for the first time.

Shares of the Seattle-based genomics firm rose as much as 9 percent in Thursday morning trading on the Nasdaq and were up 12 percent over the last two days.

The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.

The proteomics firm is in talks to either spin off its SomaSignal assays unit or to partner with another company to boost its diagnostics efforts.

The firm isn’t planning a strategy for a kitted version of the test, though company officials said they were open to that in the future.

A company spokesperson said that the macroeconomic environment is impacting customers and that the firm expects those challenges to continue into 2023.

Biosecurity services revenues for Ginkgo’s Concentric subsidiary, including COVID-19 testing, ticked up 6 percent year over year to $36.5 million.

The San Diego-based sequencing instrument maker continued to report no revenues but beat the Wall Street bottom-line estimate.